banner https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4

uniQure’s AMT-130 Delivers Game-Changing 75% Slowdown in Huntington’s Progression – Why QURE Stock is Exploding Today

Listen up, folks – if you’re glued to the markets like I am, you’ve probably seen the screens lighting up with one name this morning: uniQure, ticker QURE. As of this writing, early in the trading session on September 24, 2025, shares are rocketing higher by more than 200%, turning heads and wallets alike. That’s … Read more

UniQure N.V. (QURE) Soars on FDA Breakthrough Therapy Designation for Huntington’s Disease Treatment

As of this writing, UniQure N.V.’s stock price has surged 35.89% to $12.79 per share after the company announced that it had received a Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for its gene therapy candidate AMT-130 in treating Huntington’s disease. This significant development is not only good news for patients … Read more

banner banner https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4